Table 1 Clinical and biological characteristics of the study group
Group 1 (n = 10) | Group 2 (n = 15) | Group 3 (n = 25) | p Value | |
|---|---|---|---|---|
Age (years) | 7.5* (4.3–11.7) | 6.7* (5.0–7.6) | 6.4* (5.8–9.4) | 0.611 |
Sex (male/female) | 4/6 | 8/7 | 12/13 | 0.832 |
Age at diagnosis of KD (years) | 2.9* (1.2-6.4) | 2.1* (1.0-3.2) | NA | 0.952 |
Follow-up interval (years) | 3.4* (1.1-3.9) | 4.5* (4.0-4.9) | NA | 0.243 |
Height (cm) | 122.0 ± 29.2 | 111.8 ± 15.5 | 119.7 ± 15.7 | 0.450 |
Weight (kg) | 28.4 ± 13.6 | 21.0 ± 6.3 | 23.0 ± 7.5 | 0.514 |
BMI (kg/m2) | 17.2 ± 2.3 | 16.5 ± 1.6 | 15.7 ± 1.5 | 0.120 |
Systolic BP (mm Hg) | 94.4 ± 5.7 | 95.8 ± 6.0 | 96.4 ± 7.0 | 0.807 |
Diastolic BP (mm Hg) | 54.0 ± 5.4 | 53.6 ± 6.9 | 55.7 ± 5.2 | 0.234 |
HR (beats/min) | 87.0 ± 17.4 | 91.9 ± 17.8 | 86.5 ± 13.5 | 0.324 |
TC (mg/dL) | 183.6 ± 30.6 | 168.9 ± 21.6 | 170.6 ± 22.7 | 0.247 |
HDL-C (mg/dL) | 61.0 ± 26.0 | 58.8 ± 11.5 | 62.8 ± 12.2 | 0.335 |
LDL-C (mg/dL) | 97.9 ± 13.1 | 92.3 ± 15.5 | 90.6 ± 24.3 | 0.593 |
TC/HDL-C | 3.3 ± 0.8 | 3.0 ± 0.6 | 2.8 ± 0.6 | 0.458 |
Triglyceride (mg/dL) | 94.3 ± 47.1 | 88.3 ± 37.7 | 79.4 ± 39.5 | 0.483 |
Uric Acid (mg/dL) | 4.5 ± 0.9 | 3.9 ± 0.8 | 3.9 ± 1.2 | 0.180 |
Hemoglobin A1c (%) | 5.2 ± 0.4 | 5.4 ± 0.3 | 5.4 ± 0.3 | 0.869 |
NT-pro BNP (pg/mL) | 42.8 ± 19.7 | 61.2 ± 24.8 | 55.5 ± 21.8 | 0.192 |